LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis

Published:2019-07 Issue: Volume:228 Page:135-144
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Zhang Hualong,Zhao Bin,Wang Xiuxia,Zhang Fan,Yu Wenlong

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference43 articles.

1. Updates in the evaluation and management of breast cancer;O'Sullivan;Mayo Clin. Proc.,2018

2. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

3. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

4. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues;Chen;Gene,2016

5. Effect of curcumin and paclitaxel on breast carcinogenesis;Quispe-Soto;Int. J. Oncol.,2016

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging roles of LINC00511 in breast cancer development and therapy;Frontiers in Oncology;2024-08-14

2. YY1-induced lncRNA00511 promotes melanoma progression via the miR-150-5p/ADAM19 axis;American Journal of Cancer Research;2024

3. Research Progress on the Effect of lncRNA on Chemoresistance of Breast Cancer;Advances in Clinical Medicine;2024

4. LINC00968 and LINC00511 Regulate Gefitinib-Induced Proliferation Inhibition and Apoptosis and Drug Resistance-Related Genes in Non-Small-Cell Lung Cancer;J BIOL REG HOMEOS AG;2023

5. The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision;Non-Coding RNA;2023-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3